FDA Inspection 1044697 — Biocon Limited
The FDA completed an inspection of Biocon Limited on Mar 16, 2018 in Bangalore. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 16, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bangalore (India)
Additional Details
Postmarket Adverse Drug Experience (PADE)